First Evidence of 'nearly Universal' Pharmacological Chaperone for Rare Disease

Researchers have found evidence of a 'nearly universal' pharmacological chaperone for treating rare diseases, potentially leading to new treatment options; however, the lack of comments suggests a wait-and-see approach from the HN community.

Snapshot generated from the HN discussion